---
title: "Buddyin - Reviews, Revenue and Downloads in South Korea | Apple App Store"
description: "[임상시험용 의료기기 소프트웨어] -연구번호: ND-02 -제품명 및 모델명:NDTx-01 -제조번호 및 제조년월일:NDTx-0 1(v2.0) / 2024년 07월 01일 -보관(저장)방법: 해당사항없음. -제조업자 또는 수입업자의 상호:(주) 뉴다이브  임상시험용 외의 목적으로 사용할 수 없음"
---

# Buddyin — South Korea
> 버디인

![Buddyin App Icon](https://is1-ssl.mzstatic.com/image/thumb/Purple221/v4/1b/97/f1/1b97f113-9471-a42e-2592-06764ca22b8b/AppIcon-0-0-1x_U007emarketing-0-7-0-85-220.png/434x0w.png)

**Developer:** [Unknown](https://apptail.io/developer/unknown-nonWH)
**Category:** Health Fitness
**Rating:** N/A (0 ratings)
**Price:** Free
**Bundle ID:** com.Neudive.BuddyIn1
**Store:** Apple App Store
**Country:** South Korea
**Version:** 1.3 (released 2024-09-16)
**Original Release:** 2024-08-30
**Languages:** English

**App Store Link:** [Download on Apple App Store](https://apps.apple.com/kr/app/app/id6596801476)
**AppTail Page:** [https://apptail.io/app/buddyin-fcjy/south-korea](https://apptail.io/app/buddyin-fcjy/south-korea)

## Buddyin Description
[임상시험용 의료기기 소프트웨어]
-연구번호: ND-02
-제품명 및 모델명:NDTx-01
-제조번호 및 제조년월일:NDTx-0 1(v2.0) / 2024년 07월 01일
-보관(저장)방법: 해당사항없음.
-제조업자 또는 수입업자의 상호:(주) 뉴다이브

임상시험용 외의 목적으로 사용할 수 없음

## Buddyin Screenshots
- [Screenshot 1](https://is1-ssl.mzstatic.com/image/thumb/PurpleSource211/v4/9a/ea/ae/9aeaae2e-05d8-a309-a65a-9d539c172acf/0958e9ab-2e86-47af-a35f-354c12a35ed9_processed_image_2.png/1242x2208.png)
- [Screenshot 2](https://is1-ssl.mzstatic.com/image/thumb/PurpleSource211/v4/c0/09/48/c00948e2-733d-5a43-622f-ab165e749779/ad3a92ff-a432-481e-8d32-074beca97ab3_processed_image_7.png/1242x2208.png)
- [Screenshot 3](https://is1-ssl.mzstatic.com/image/thumb/PurpleSource211/v4/61/2c/1d/612c1dd3-fdbc-cb12-d9ea-88ed59b01548/9ee1a22a-ba00-4d47-97c0-01be821816e3_processed_image_4.png/1242x2208.png)
- [Screenshot 4](https://is1-ssl.mzstatic.com/image/thumb/PurpleSource221/v4/b7/67/93/b76793eb-2731-7594-1064-8ced2eaaa849/75a40a0b-315f-493b-8de0-e38bb1115319_processed_image_6.png/1242x2208.png)
- [Screenshot 5](https://is1-ssl.mzstatic.com/image/thumb/PurpleSource211/v4/1a/61/57/1a6157eb-da23-3752-5c6f-55721b170b5c/08a96a35-a754-4d36-8683-49126f8ba030_processed_image_5.png/1242x2208.png)
- [Screenshot 6](https://is1-ssl.mzstatic.com/image/thumb/PurpleSource221/v4/57/3e/6c/573e6cb5-5a68-1b11-51cd-ca53703c8ef4/72e2f329-a3ed-419c-b701-8201bee83fd7_processed_image_1.png/1242x2208.png)
- [Screenshot 7](https://is1-ssl.mzstatic.com/image/thumb/PurpleSource221/v4/da/72/cf/da72cf03-8e39-8d17-c39f-5a12b608cd58/6219df2a-1b37-4b2f-a013-cbcda8d59f90_processed_image_3.png/1242x2208.png)






## Apps Similar to Buddyin
- [WHOYOU (후유)](https://apptail.io/app/whoyou-XUDl/south-korea)
- [repeech](https://apptail.io/app/repeech-Yenn/south-korea)
- [숨이랑(Soomirang)](https://apptail.io/app/soomirang-IpEo/south-korea)
- [마음편의점](https://apptail.io/app/app-Aphp/south-korea)
- [브레인오케이 - 5분 안에 치매 위험 탐지](https://apptail.io/app/5-kqlq/south-korea)
- [PixelMood](https://apptail.io/app/pixelmood-DGpq/south-korea)
- [WithBuddy](https://apptail.io/app/withbuddy-uBss/south-korea)
- [forA – ADHD 커뮤니티, 약 후기·정보, 매거진](https://apptail.io/app/fora-adhd-rkhv/south-korea)
- [2025년도 대한신경정신의학회 춘계학술대회](https://apptail.io/app/2025-dclv/south-korea)
- [뽀미](https://apptail.io/app/app-DNMw/south-korea)

## Buddyin Available In
- [South Korea](https://apptail.io/app/buddyin-fcjy/south-korea)
- [United States](https://apptail.io/app/buddyin-fcjy/united-states)

---

## About AppTail

[AppTail](https://apptail.io) is a mobile app intelligence platform providing app analytics, ASO (App Store Optimization) tools, keyword tracking, competitor analysis, revenue estimates, and review monitoring for iOS App Store apps. Track your app's performance, discover ranking keywords, monitor competitors, and analyze market trends.

- [Search Apps](https://apptail.io)
- [Top Charts](https://apptail.io/top-iphone-apps)
- [Sign Up for Full Access](https://app.apptail.io/signup?utm_campaign=ai-crawl&amp;utm_content=footer)

*Data provided by [AppTail](https://apptail.io) - Mobile App Intelligence Platform*
